share_log

HC Wainwright & Co. Reiterates Buy on Lyell Immunopharma, Maintains $9 Price Target

Benzinga ·  May 5, 2023 06:54

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Lyell Immunopharma (NASDAQ:LYEL) with a Buy and maintains $9 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment